| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.73B | 69.33B | 67.08B | 61.95B | 59.03B | 51.74B |
| Gross Profit | 30.65B | 31.45B | 30.20B | 27.62B | 26.30B | 22.88B |
| EBITDA | 10.97B | 11.13B | 10.61B | 9.73B | 9.27B | 7.22B |
| Net Income | 6.94B | 5.92B | 6.47B | 5.30B | 5.53B | 3.57B |
Balance Sheet | ||||||
| Total Assets | 68.24B | 75.28B | 69.00B | 71.99B | 69.42B | 59.24B |
| Cash, Cash Equivalents and Short-Term Investments | 12.85B | 13.76B | 13.35B | 14.64B | 15.00B | 11.88B |
| Total Debt | 13.17B | 12.75B | 13.58B | 17.84B | 21.82B | 19.37B |
| Total Liabilities | 24.96B | 25.70B | 26.20B | 34.22B | 36.84B | 32.19B |
| Stockholders Equity | 43.17B | 49.48B | 42.71B | 37.67B | 32.50B | 24.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.42B | 5.05B | 5.49B | 3.21B | -289.00M |
| Operating Cash Flow | 0.00 | 6.47B | 6.58B | 7.17B | 4.10B | 1.78B |
| Investing Cash Flow | 0.00 | -3.79B | -2.00B | -2.01B | -1.36B | -2.40B |
| Financing Cash Flow | 0.00 | -2.91B | -5.44B | -5.64B | 452.00M | -741.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥169.90B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
79 Outperform | ¥1.08T | 21.67 | 11.99% | 0.65% | 8.38% | 8.43% | |
76 Outperform | ¥336.67B | 15.78 | ― | 2.04% | -8.82% | 18.33% | |
72 Outperform | ¥72.74B | 6.77 | ― | 2.31% | 3.34% | -8.24% | |
70 Outperform | ¥1.10T | 17.62 | 11.14% | 1.46% | 4.02% | 13.81% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥1.08T | 15.40 | 2.99% | 2.62% | -4.29% | 75.25% |